Single Shot Fascia Iliaca Block vs Femoral Nerve Block for Analgesia for Surgical Fixation of Hip Fractures

A Randomized Controlled Trial Comparing Single Shot Fascia Iliaca Block With Femoral Nerve Block for Analgesia Following Surgical Fixation of Hip Fractures

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02330302

Enrollment

Registered

2015-01-01

Start date

2014-08-31

Completion date

2015-08-31

Last updated

2018-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Fracture

Brief summary

Hip fractures are common in our elderly population and is associated with pain before and after surgery. The current pain management for patients who have undergone surgery for hip fractures include a combination of oral painkillers, opioids (eg morphine) and regional anaesthesia techniques, which involves the injection of local anaesthetic drugs near nerves supplying the hip joint to numb the operation site. As opioids have many side effects, especially in the elderly patients, regional anaesthesia techniques can help to reduce the use of opioids and the related side effects. This may enhance their recovery and length of hospital stay

Interventions

DRUGRopivacaine

Ultrasound-guided femoral nerve block with Ropivacaine 0.5% 30mls

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients scheduled for surgical fixation of hip fracture * Patients with isolated inter-trochantric fracture * American Society of Anesthesiologists (ASA) physical status 1 to 3 * Patients who are able to give their own consent

Exclusion criteria

* Patients unable to give consent or inability to communicate/ cooperate * Patients with regular consumption of strong opioids (morphine, oxycodone) or steroids * Patients with allergy to local anaesthetics or any drugs included in the study * Patients with contraindications to spinal anaesthesia such as coagulation disorders/ thrombocytopenia and local infection at site of injection

Design outcomes

Primary

Measure	Time frame	Description
Pain scores	up to 24 hours	resting and dynamic pain scores are obtained pre-intervention, 30mins post intervention (and on positioning for spinal anaesthesia), 1 hr post-operatively and at 24hrs post intervention

Secondary

Measure	Time frame	Description
opioid requirement/consumption	for first 24 hrs (including intra operatively) following intervention	need for additional opioids during first 24hrs following intervention record of any opioid related side effects will be kept as well

Other

Measure	Time frame	Description
complications associated with intervention	at 24 hrs post intervention	including hematoma, infection, prolonged neurologic deficits, occurence of falls

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026